Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Grundman

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 23, 2014
Understanding the relative importance of preserving functional abilities in Alzheimer's disease in the United States and GermanyA Brett Hauber, Ateesha F Mohamed, F Reed Johnson, et al.
Sleep|December 6, 2003
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's diseaseClifford Singer, Rochelle E Tractenberg, Jeffrey Kaye, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 19, 2025
Phase 2 study of zervimesine (CT1812) in participants with mild-to-moderate dementia with Lewy bodies (DLB)James E Galvin, Magdalena I Tolea, Douglas W Scharre, et al.
Alzheimer Disease and Associated Disorders|August 30, 2008
Older Americans' risk-benefit preferences for modifying the course of Alzheimer diseaseA Brett Hauber, F Reed Johnson, Howard Fillit, et al.
The Clinical Neuropsychologist|February 14, 2014
Cognition in MCI and Alzheimer's disease: baseline data from a longitudinal study of the NTBJohn Harrison, Dorene M Rentz, Trent McLaughlin, et al.
Current Alzheimer Research|April 10, 2009
Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody respondersBruno Vellas, R Black, Leon J Thal, et al.
Dementia and Geriatric Cognitive Disorders|January 9, 2016
Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use CriteriaMichael Grundman, Keith A Johnson, Ming Lu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2012
Improving Alzheimer's disease phase II clinical trialsBarry D Greenberg, Maria C Carrillo, J Michael Ryan, et al.
Neurobiology of Aging|April 25, 2007
Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCIClifford R Jack, Ronald C Petersen, Michael Grundman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2016
First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteersDale B Schenk, Martin Koller, Daniel K Ness, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 23, 2014
Understanding the relative importance of preserving functional abilities in Alzheimer's disease in the United States and GermanyA Brett Hauber, Ateesha F Mohamed, F Reed Johnson, et al.
Sleep|December 6, 2003
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's diseaseClifford Singer, Rochelle E Tractenberg, Jeffrey Kaye, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 19, 2025
Phase 2 study of zervimesine (CT1812) in participants with mild-to-moderate dementia with Lewy bodies (DLB)James E Galvin, Magdalena I Tolea, Douglas W Scharre, et al.
Alzheimer Disease and Associated Disorders|August 30, 2008
Older Americans' risk-benefit preferences for modifying the course of Alzheimer diseaseA Brett Hauber, F Reed Johnson, Howard Fillit, et al.
The Clinical Neuropsychologist|February 14, 2014
Cognition in MCI and Alzheimer's disease: baseline data from a longitudinal study of the NTBJohn Harrison, Dorene M Rentz, Trent McLaughlin, et al.
Current Alzheimer Research|April 10, 2009
Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody respondersBruno Vellas, R Black, Leon J Thal, et al.
Dementia and Geriatric Cognitive Disorders|January 9, 2016
Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use CriteriaMichael Grundman, Keith A Johnson, Ming Lu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2012
Improving Alzheimer's disease phase II clinical trialsBarry D Greenberg, Maria C Carrillo, J Michael Ryan, et al.
Neurobiology of Aging|April 25, 2007
Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCIClifford R Jack, Ronald C Petersen, Michael Grundman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2016
First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteersDale B Schenk, Martin Koller, Daniel K Ness, et al.
Pageof 8